Idexx Laboratories, Inc.

NASDAQ: IDXX    
Share price (4/24/24): $494.26    
Market cap (4/24/24): $41.1 billion
Search in Documents
Key Exhibits
External Links
18 Idexx Laboratories, Inc. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.50
from 10-K 13 pages Employee Leveraged Restricted Stock Unit Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56
EX-10.28
from 10-K 2 pages Idexx Laboratories, Inc. Executive Incentive Plan Summary of Bonus Determination Process as of Performance Year Beginning 1/1/2024
12/34/56
EX-10.1
from 10-Q 2 pages Certain Confidential Information Contained in This Document, Marked by Asterisks [**], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. July 28, 2023
12/34/56
EX-10.27
from 10-K 2 pages Idexx Laboratories, Inc. Executive Incentive Plan Summary of Bonus Determination Process as of Performance Year Beginning 1/1/2023
12/34/56
EX-10.1
from 10-Q 9 pages Confidential Information, Work Product, and Restrictive Covenant Agreement
12/34/56
EX-10.44
from 10-K 6 pages CEO Stock Option Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56
EX-10.43
from 10-K 7 pages CEO Restricted Stock Unit Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56
EX-10.42
from 10-K 2 pages Restricted Stock Unit Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56
EX-10.41
from 10-K 7 pages Employee Restricted Stock Unit Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56
EX-10.34
from 10-K 6 pages Employee Stock Option Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56
EX-10.29
from 10-K 2 pages Director Restricted Stock Unit Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56
EX-10.28
from 10-K 2 pages Director Stock Option Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56
EX-10.22
from 10-K 6 pages Idexx Laboratories, Inc. Director Deferred Compensation Plan Restated Effective as of October 13, 2021
12/34/56
EX-10.19
from 10-K 3 pages Certain Confidential Information Contained in This Document, Marked by Asterisks, Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. November 2, 2021 1. Agreement Between Ortho and [**]; Catalyst Work Center 5 Costs
12/34/56
EX-10.16
from 10-K 3 pages Amendment No. 6 to Agreement
12/34/56
EX-10.14
from 10-K 13 pages Amendment No.4 to Agreement
12/34/56
EX-10.13
from 10-K 4 pages Amendment No. 3 to Agreement
12/34/56
EX-10.11
from 10-K 8 pages Amendment No. 1 to Agreement
12/34/56
EX-10.10
from 10-K 41 pages Agreement
12/34/56
EX-10.9
from 10-K 3 pages Amendment No. 8 to Agreement
12/34/56